Personal real-time continuous glucose monitoring in patients 65 years and older

Endocrine Practice

Volumn 20, Issue 12, 2014, Pages 1297-1302

  Argento, Nicholas B ^a   Nakamura, Katherine ^b  

^a Maryland Endocrine   (Colombia)

^b DexCom Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLYCEMIC CONTROL; GROUPS BY AGE; HEALTH INSURANCE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERSONAL MONITORING; PERSONAL REAL TIME CONTINUOUS GLUCOSE MONITORING; GLUCOSE BLOOD LEVEL; RETROSPECTIVE STUDY;

AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; RETROSPECTIVE STUDIES;

EID: 84919973702     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP14017.OR     Document Type: Article

References (17)

1. JDRF Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) trial. Diabetes Care. 2010:33:17-22.
2. JDRF Continuous Glucose Monitoring Study Group, Beck RW, Hirsch IB, et al. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009;32:1378-1383.
3. Bailey TS, Zisser HC, Garg SK. Reductions in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther. 2007;9:203-210.
4. Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-Augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363:311-320.
5. Battelino T, Philip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011;34: 795-800.
6. Terreni A, Paleari R, Caldini A, Ognibene A, Mosca A, Messeri G. Evaluation of the analytic performances of the new HPLC system HLC-723 G7 for the measurement of hemoglobin A1c. Clin Biochem. 2003;36:607-610.
7. Abadie JM, Koelsch AA. Performance of the Roche second generation hemoglobin A1c immunoassay in the presence of HB-S or HB-C traits. Ann Clin Lab Sci. 2008; 38:31-36.
8. Tosoh Bioscience, Inc. G7 Automated HPLC analyzer operator's manual, 2002.
9. Roche Diagnostics. Tina-quant Hemoglobin A1c Gen.2 package insert, 11-2011.
10. Schütt M, Fach EM, Seufert J, et al. Multiple complications and frequent severe hypoglycaemia in 'elderly' and 'old' patients with Type 1 diabetes. Diabet Med. 2012;29: e176-e179.
11. Weinstock RS, Xing D, Maahs DM, et al. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab. 2013;98:3411-3419.
12. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36:1384-1395.
13. McCoy RG, Shah ND, Van Houten HK, et al. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care. 2012;35:1897-1901.
14. American Diabetes Association. Standards of Medical Care in Diabetes 20 Diabetes Care. 2013;36 Suppl 1: S11-S66.
15. Klonoff DC, Buckingham B, Christiansen JS, et al. continuous glucose monitoring: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96: 2968-2979.
16. Center for Medicare and Medicaid Services. Available at: http://www.CMS.gov. Accessed November 10, 2013.
17. Dexcom CGM Resource Center. Available at: http://dexcom. com/reimbursement. Accessed November 10, 2013.